Cubist buys private antibiotic firm for up to $403 million
Cubist Pharmaceuticals is to buy the private biopharmaceutical company Calixa Therapeutics for up to $402.5 million.
Cubist Pharmaceuticals is to buy the private biopharmaceutical company Calixa Therapeutics for up to $402.5 million.